Urothelial Carcinoma of the Bladder
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma of the Bladder.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-02-19EMA Authorised: Balversa (Erdafitinib) — Janssen-Cilag International N.V.
The European Medicines Agency authorised Balversa (erdafitinib) for urothelial carcinoma of the bladder.
-
FDA approval · 2010-05-28FDA Approved: CYSVIEW — Original Application (Photocure Inc.)
CYSVIEW (hexaminolevulinate hydrochloride) was approved by the FDA as an imaging agent to be used with blue-light cystoscopy to help detect …